Maxcyte (MXCT) Interest Coverage Ratio (QoQ) (2020 - 2026)
Maxcyte (MXCT) Interest Coverage Ratio (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -69.26% |
| Mar 31, 2026 | -1,430.00% |
| Dec 31, 2025 | 91.39% |
| Sep 30, 2025 | 66.17% |
| Jun 30, 2025 | -1,157.96% |
| Mar 31, 2025 | -95.85% |
| Dec 31, 2024 | 55.32% |
| Sep 30, 2024 | -19.76% |
| Jun 30, 2024 | 91.83% |
| Mar 31, 2024 | -953.82% |
| Dec 31, 2023 | 72.52% |
| Sep 30, 2023 | 74.10% |
| Jun 30, 2023 | 0.80% |
| Mar 31, 2023 | -2,452.47% |
| Dec 31, 2022 | 10.01% |
| Sep 30, 2022 | 93.60% |
| Jun 30, 2022 | -2,908.88% |
| Sep 30, 2021 | -20.00% |
| Jun 30, 2021 | 98.16% |
| Mar 31, 2021 | -19,975.60% |